There were individual volunteer donors who demonstrated IFN-γ responses to some of the identified epitopes and proteins (Figure 2B) and those positive responses were no different from the responses observed in colorectal cancer patients (p>0.05 for all). This evidence concerns the gene IFNG and colorectal cancer.